Fate Therapeutics (NASDAQ:FATE) reported its Q4 earnings results on Monday, February 26, 2024 at 04:01 PM. Here’s what investors need to know about the announcement. EarningsFate Therapeutics beat estimated earnings by 13.0%, reporting an EPS of $-0.45 versus an estimate of $-0.52. Revenue was down $42.68 million from the same period last year. Past Earnings PerformanceLast quarter the company beat on EPS by $0.11 which was followed by a 9.0% drop in the share price the next day. Here’s a look at Fate Therapeutics’s past performance: To track all earnings releases for Fate Therapeutics visit t…